We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
bioAffinity Technologies Inc | NASDAQ:BIAF | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.21 | -9.17% | 2.08 | 1.00 | 13.83 | 2.2511 | 2.03 | 2.24 | 116,956 | 05:00:09 |
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 |
OMB APPROVAL
OMB Number: 3235-0287 Estimated average burden hours per response... 0.5 |
| |
1. Name and Address of Reporting Person * Rubin Gary D | 2. Issuer Name and Ticker or Trading Symbol bioAffinity Technologies, Inc. [ BIAF ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director __X__ 10% Owner _____ Officer (give title below) _____ Other (specify below) |
3. Date of Earliest Transaction
(MM/DD/YYYY)
| ||
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
1.Title of Security (Instr. 3) | 2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code (Instr. 8) |
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock (1) | 9/6/2022 | C | 15876 (4) | A | $4.20 (4) | 51590 | D (2) | |||
Common Stock (1) | 9/6/2022 | C | 266850 (5) | A | $4.20 (5) | 1082866 | I | By Trust (3) | ||
Common Stock (1) | 9/6/2022 | C | 38287 (6) | A | $4.20 (6) | 1121153 | I | By Trust (3) | ||
Common Stock (1) | 9/6/2022 | C | 93821 (7) | A | $4.20 (7) | 1214974 | I | By Trust (3) | ||
Common Stock (1) | 9/6/2022 | C | 63958 (8) | A | $4.20 (8) | 1278932 | I | By Trust (3) | ||
Common Stock (1) | 9/6/2022 | C | 58577 (9) | A | $4.20 (9) | 1337509 | I | By Trust (3) | ||
Common Stock (1) | 9/6/2022 | C | 230309 (10) | A | $5.17 (10) | 1567818 | I | By Trust (3) | ||
Common Stock (1) | 8/31/2022 | P | 16326 | A | (11) | 1584144 | I | By Trust (3) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Secured Convertible Promissory Note (1) | $4.20 (4) | 9/6/2022 | C | $66682.86 | 9/6/2022 (4) | 10/31/2022 | Common Stock | 15876 | $0 | 0 | D | ||||
Secured Convertible Promissory Note (1) | $4.20 (5) | 9/6/2022 | C | $1120773.84 | 9/6/2022 (5) | 10/31/2022 | Common Stock | 266850 | $0 | 0 | I | By Trust (3) | |||
Secured Convertible Promissory Note (1) | $4.20 (6) | 9/6/2022 | C | $160808.22 | 9/6/2022 (6) | 10/31/2022 | Common Stock | 38287 | $0 | 0 | I | By Trust (3) | |||
Secured Convertible Promissory Note (1) | $4.20 (7) | 9/6/2022 | C | $394048.22 | 9/6/2022 (7) | 10/31/2022 | Common Stock | 93821 | $0 | 0 | I | By Trust (3) | |||
Secured Convertible Promissory Note (1) | $4.20 (8) | 9/6/2022 | C | $268626.30 | 9/6/2022 (8) | 10/31/2022 | Common Stock | 63958 | $0 | 0 | I | By Trust (3) | |||
Secured Convertible Promissory Note (1) | $4.20 (9) | 9/6/2022 | C | $246027.40 | 9/6/2022 (9) | 10/31/2022 | Common Stock | 58577 | $0 | 0 | I | By Trust (3) | |||
Series A Convertible Preferred Stock (1) | $5.17 (10) | 9/6/2022 | C | 1612163 | (10) | (10) | Common Stock | 230309 | $0 | 0 | I | By Trust (3) | |||
Warrants (right to buy) (1) | $7.35 (11) | 8/31/2022 | P | 16326 | 8/31/2022 | 8/31/2027 | Common Stock | 16326 | (11) | 16326 | I | By Trust (3) | |||
Non-tradeable Warrants (right to buy) (1) | $7.656 (11) | 8/31/2022 | P | 16326 | 8/31/2022 | 8/31/2027 | Common Stock | 16326 | (11) | 16326 | I | By Trust (3) | |||
Warrants (right to buy) (1) | $6.125 (12) | 9/6/2022 | A | 12241 | 9/6/2022 (12) | 8/25/2026 | Common Stock | 12241 | (12) | 12241 | D | ||||
Warrants (right to buy) (1) | $6.125 (13) | 9/6/2022 | P | 408125 (13) | 9/6/2022 (13) | 8/25/2026 | Common Stock | 408125 | (13) | 408125 | I | By Trust (3) | |||
Warrants (right to buy) (1) | $5.25 | 7/20/2022 | A | 4896 | 7/20/2022 | 7/20/2027 | Common Stock | 4896 | (14) | 4896 | D | ||||
Warrants (right to buy) (1) | $5.25 | 7/20/2022 | P | 163248 (15) | 7/20/2022 | 7/20/2027 | Common Stock | 163248 | (15) | 163248 | I | By Trust (3) |
Remarks: Exhibit List - Exhibit 24.1: Power of Attorney (Gary D. Rubin) Exhibit 24.2: Power of Attorney (Harvey Sandler Revocable Trust) |
Reporting Owners | |||||
Reporting Owner Name / Address | |||||
Director | 10% Owner | Officer | Other | ||
Rubin Gary D 2080 NW BOCA RATON BLVD, STE 2 BOCA RATON, FL 33431 | X | X | |||
Harvey Sandler Revocable Trust C/O GARY RUBIN, CO-TRUSTEE 2080 NW BOCA RATON BLVD, STE 2 BOCA RATON, FL 33431 | X |
Signatures | ||
/s/ Wilhelm E. Liebmann, as attorney-in-fact for Gary D. Rubin | 10/21/2022 | |
**Signature of Reporting Person | Date | |
/s/ Wilhelm E. Liebmann,, as attorney-in-fact for Gary D. Rubin, the Co-Trustee of the Harvey Sandler Revocable Trust | 10/21/2022 | |
**Signature of Reporting Person | Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1 Year bioAffinity Technologies Chart |
1 Month bioAffinity Technologies Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions